News Daily News FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI Michael O'Riordan January 26, 2026
News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
News Conference News ACC 2025 PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data Caitlin E. Cox March 31, 2025
Presentation ACC 2025 Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial Presenter: William Fearon March 30, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2024 Caitlin E. Cox December 31, 2024
News Daily News Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3 Todd Neale December 09, 2024
Presentation TCT 2024 TCT 23: Outcomes After FFR-Guided PCI Compared With CABG in Patients Presenting With Acute Coronary Syndrome: A Pre-Specified Subgroup Analysis of the FAME 3 Trial Presenter: Kuniaki Takahashi October 28, 2024
News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Daily News PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone Michael O'Riordan November 24, 2023
Presentation TCT 2023 TCT 142: Impact of Chronic Total Occlusions on Outcomes in The FAME 3 Trial Presenter: Hisao Otsuki October 24, 2023
News Daily News ‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease Michael O'Riordan September 13, 2023
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News STS 2023 Large Medicare Analysis Reopens Debate Over Multivessel Revascularization Yael L. Maxwell January 24, 2023
News Opinion Conversations in Cardiology Conversations in Cardiology: ISCHEMIA’s Lasting Fallout December 29, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022